CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Treatments Other than Sorafenib for Patients with Advanced Hepatocellular Carcinoma
Do Seon Song, Si Hyun Bae
J Liver Cancer. 2016;16(1):1-6.   Published online March 31, 2016
DOI: https://doi.org/10.17998/jlc.16.1.1

Excel Download

Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
Journal of Gastroenterology and Hepatology. 2011;26(11):1612-1618   Crossref logo
Link1 Link2

The Efficacy of Sorafenib for Patients With Advanced Hepatocellular Carcinoma
The Korean Journal of Hepatology. 2007;13(4):576   Crossref logo
Link1 Link2 Link3

Vitamin K1 plus Sorafenib Combination is More Effective than Sorafenib Alone in Advanced Hepatocellular Carcinoma - a Prospective Randomized Controlled Trial
Journal of Hepatology. 2016;64(2):S691   Crossref logo
Link1 Link2

Camrelizumab combined with sorafenib versus sorafenib alone in patients with advanced hepatocellular carcinoma: a retrospective study
. 2021;   Crossref logo
Link1 Link2

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma
The Korean Journal of Hepatology. 2009;15(2):227   Crossref logo
Link1 Link2 Link3

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
Journal of Hepatocellular Carcinoma. 2015;39   Crossref logo
Link1

FOLFOX4 or sorafenib as the first-line treatments for advanced hepatocellular carcinoma: A cost-effectiveness analysis
Digestive and Liver Disease. 2016;48(12):1492-1497   Crossref logo
Link1 Link2

Intra-arterial treatments in patients with hepatocellular carcinoma
Alimentary Pharmacology & Therapeutics. 2003;17:111-118   Crossref logo
Link1 Link2 Link3

Factors Affecting Therapeutic Effects in 17 Patients with Advanced Hepatocellular Carcinoma Who Were Treated with Sorafenib for More than 12 Months
Case Reports in Oncology. 2018;11(3):711-720   Crossref logo
Link1 Link2

Sorafenib use in hepatocellular carcinoma: More questions than answers
Hepatology. 2014;60(1):15-18   Crossref logo
Link1 Link2